Nomenclature |
Peptide transporter
1
|
Peptide transporter
2
|
Peptide transporter
3
|
Peptide transporter
4
|
Systematic nomenclature |
SLC15A1 |
SLC15A2 |
SLC15A3 |
SLC15A4 |
Common abreviation |
PepT1 |
PepT2 |
PHT2 |
PHT1 |
HGNC, UniProt |
SLC15A1,
P46059
|
SLC15A2,
Q16348
|
SLC15A3,
Q8IY34
|
SLC15A4,
Q8N697
|
Substrates |
fMet‐Leu‐Phe
[337], cefadroxil
[177], valacyclovir
[178], cyclacillin
[177], muramyl
dipeptide [496] |
cefadroxil
[177], cyclacillin
[177] |
– |
valacyclovir
[37] |
Endogenous substrates |
dipeptides [135], 5‐aminolevulinic
acid [135],
tripeptides [135] |
dipeptides, 5‐aminolevulinic
acid, tripeptides |
L‐histidine,
carnosine,
dipeptides, tripeptides |
carnosine,
L‐histidine,
dipeptides, tripeptides |
Stoichiometry |
2 H+ : 1 zwitterionic
peptide (in) |
2 H+ : 1 zwitterionic
peptide (in) |
Unknown |
Unknown |
Inhibitors |
Lys[Z(NO2)]‐Pro (pK
i 5) [283], 4‐AMBA
[107] |
Lys[Z(NO2)]‐Lys[Z(NO2)]
[40, 472], Lys[Z(NO2)]‐Pro
|
– |
– |
Labelled ligands |
[11C]GlySar, [14C]GlySar, [3H]GlySar
|
[11C]GlySar, [14C]GlySar, [3H]GlySar
|
[14C]histidine, [3H]histidine
|
[14C]histidine (Binding) [528], [3H]histidine
|